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hy Are (Only) Some Infarcted
earts Arrhythmogenic?*
ames P. Daubert, MD
urham, North Carolina
n this issue of the Journal, Haqqani et al. (1) provide
aluable insight as to why some patients who survive a large
yocardial infarction (MI) are prone to ventricular tachy-
ardia (VT), yet other survivors of a similar infarct are
eemingly immune. They compare 17 patients presenting
ith recurrent, sustained monomorphic ventricular tachy-
ardia (SMVT) with 17 post-MI patients undergoing pro-
hylactic implantable cardioverter-defibrillator (ICD) inser-
ion, who had so far been free from clinical episodes of
MVT. Notably, the SMVT and prophylactic ICD groups
ppeared nearly identical with regard to clinical character-
stics (Table 1 in Haqqani et al. [1]), both being almost
xclusively male, with equally depressed ejection fractions
0.28 and 0.26, respectively) and equally dilated ventricles.
he SMVT group was, on average, 8 years older, and in
iew of recurrent SMVT, 16 were taking amiodarone, often
n combination with a second antiarrhythmic agent. A
lightly longer interval since (first known) MI (9 years vs. 8
ears), a slightly longer QRS duration (144 ms vs. 132 ms),
nd a slight preponderance of inferior infarcts marked the
T group, but these differences did not approach signifi-
ance in this relatively small study.
See page 166
Why, then, had the SMVT patients “declared” them-
elves and the prophylactic ICD group not done so? The
ccurrence of an arrhythmia is often related to the conflu-
nce of a fixed substrate plus a functional, intermittent
actor or trigger. Clearly, one would conclude from the
nformation at hand (i.e., the apparently similar substrate of
he 2 groups) that the reason for one group presenting with
MVT and the other not exhibiting VT would be explained
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ics, and Medtronic.y the occurrence or absence of triggers or such factors. One
ight (wrongly) conclude that the treatment should be
irected at triggers, such as premature ventricular contrac-
ions, but that runs counter to the hard-earned lessons of
AST (Cardiac Arrhythmia Suppression Trial) (2). The
rigger hypothesis also does not fit other data—the SMVT
roup was easily inducible into multiple VT morphologies,
ut the no-VT group was largely noninducible, even when
riggers (programmed stimulation) were amply supplied (1).
espite the 2 groups’ apparently identical post-infarction
linical substrate, electroanatomic left ventricular mapping
isclosed that the VT group had much more low voltage,
nd especially very low voltage (0.5 mV), scar (1). Fur-
hermore, more of the SMVT patients’ electrograms were
ractionated or exhibited either isolated or very late poten-
ials. Several groups (3–5) have reported similar findings
ased on epicardial and/or endocardial mapping at the time
f aneurysm or VT surgery, but in these reports the non-VT
roup may not always have had as severe a cardiomyopathy (5).
The presence of prolonged, fractionated, and/or late,
solated electrograms in regions harboring VT circuits is
hus not new. The infarct border zone harboring fraction-
ted electrograms is known to be where VT can be targeted
nd eliminated, rather than the aneurysm itself. In the VT
urgery era, resected, subendocardial infarct-border tissue
ypically contained 1 or more thin bundles of viable myo-
ardium widely separated from one another by extensive
brous tissue (6). Using tissue perfusion baths, mapping of
uch explanted specimens containing the map-determined
MVT site of origin has shown remarkably complex,
zig-zag” conduction (7). Despite extremely fractionated
xtracellular electrograms, intracellular recordings were typ-
cally normal and conduction velocity was brisk (0.7 m/s)
long fiber orientation. However, transverse conduction
eandered through the scar tissue along tenuous thin tracks
ne-tenth as fast. Actual conduction paths proved to be up to
8 times longer than the linear distance between 2 points (7).
The work of Haqqani et al. (1) reinforces earlier findings
orrelating propensity to VT, with scarred regions harboring
urviving isolated myocardial bundles from the pathologist’s
erspective and fractionated, isolated electrograms as seen
y the electrophysiologist (3–5). Others have shown that
emoving this tissue surgically or ablating it with a catheter
argeting the abnormal potentials can be curative. This work
mphasizes the primacy of substrate in determining whether
T will occur, and the fact that suitable VT substrate may
r may not be present in similar sized infarcts. The older age
f the SMVT group compared with the non-VT group and
he possible tendency for increased time since infarct (not
ignificant in this small study) could fit with what we know
bout fibrosis being progressive in the post-MI period (8)
nd for there to be a greater tendency for ICD benefit later
fter an infarct (9). Yet, we do not fully know why fibrosis
ontinues to accumulate, how to predict those most at risk,
r how to prevent it.
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July 7, 2009:174–5 Why Are Some Infarcted Hearts Arrhythmogenic?Not surprisingly, a number of questions remain. Why do
he non-VT patients in the study by Haqqani et al. (1) have
ewer low voltage, abnormal electrogram sites, even though
heir ejection fractions are as depressed and their ventricles
re as dilated? Do they have more intramural or subepicar-
ial scar not as readily detected by endocardial mapping?
ut wouldn’t subepicardial scar be as prone to SMVT, as
hown by many animal infarct models and even by human
apping (3)? It is interesting to speculate what magnetic
esonance scans might have shown in the 2 groups. Re-
ently, the likelihood of an ICD firing was found to
orrelate best with the amount of inhomogeneous scar
surrounding dense homogeneous scar), likely reflecting
urviving fibers interspersed within scar tissue bordering an
nfarct (10). Patchy infarct has also been correlated patho-
ogically with late post-infarct VT (11), perhaps because
cattered, relatively larger sections of fibrosis cause more
ctivation delay than an even greater amount of very fine,
iffusely distributed, interstitial fibrosis (12). Last, does
nfarct location matter? This is a point raised by the slight
xcess of inferior infarcts in the SMVT group (nonsignifi-
ant) and the known arrhythmogenicity of mitral annular
sthmi (13,14). Data such as that presented by Haqqani et
l. (1) are scarce because patients without VT would
ndergo left ventricular mapping only for research purposes.
evertheless, limitations must be kept in mind. Although
ell conducted, the study is small and essentially devoid of
ata specific to women surviving an MI, despite a climbing
elative sudden death rate for women versus that in men
15). One cannot exclude the fact that amiodarone might
ave influenced the SMVT group’s electrograms. The
elative propensity toward ventricular fibrillation may not be
he same as that for SMVT by these criteria, since ventric-
lar fibrillation risk may not correlate with inducibility of
MVT (16). Although the electroanatomic mapping meth-
dology is widely used, the finding of low voltage is really
nly a histologic surrogate for scar, and may depend upon an
miodarone effect or the mapping modality used (17). In
onclusion, the data of Haqqani et al. (1) stress the
mportance of the peri-infarct substrate in arrhythmogen-
sis. Future goals are to replicate and correlate this type of
ata with novel imaging and/or pathologic findings, and
ith arrhythmia events in follow-up in a similar but larger
opulation, including women, as well as in nonischemic
ardiomyopathy.
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